Master Alliance Provisions Guide (MAPGuide)

IMI 2 Model Grant Agreement

  • Protecting & sharing information | Publication of Results

28. Exploitation of Results


28.2 Results that could contribute to European or International Standards – Information on JU funding and support from JU members. If results are incorporated in a standard, the beneficiary concerned must — unless the JU requests or agrees otherwise or unless it is impossible — ask the standardization body to include the following statement in (information related to) the standard: “Results incorporated in this standard received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No [number]. The JU receives support from the  European Union’s Horizon 2020 research and innovation programme and [insert names of the JU members other than the EU] [and [insert name(s) of the Associated Partner(s)]].”.

29. Dissemination of Results – Open Access – Visibility of JU Funding and Support from JU Members

29.1 Obligation to disseminate results. Unless it goes against their legitimate interests, each beneficiary must — as soon as possible — “disseminate” its results by disclosing them to the public by appropriate means (other than those resulting from protecting or exploiting the results), including in scientific publications (in any medium). […]

29.2 Open access to scientific publications. Each beneficiary must ensure open access (free of charge, online access for any user) to all peer-reviewed scientific publications relating to its results. Each beneficiary must ensure open access (free of charge, online access for any user) to all peer-reviewed scientific publications relating to its results. […]

29.3. Open Access to Research Data

[OPTION 1a for actions participating in the Open Research Data Pilot: Regarding the digital research data generated in the action (“data”), the beneficiaries must:

(a) deposit in a research data repository and take measures to make it possible for third parties to access, mine, exploit, reproduce and disseminate — free of charge for any user — the following: (i) the data, including associated metadata, needed to validate the results presented in scientific publications as soon as possible; (ii) [Option A for health actions that participate in the Open Research Data Pilot, if foreseen in the work plan: data which is relevant for addressing a public health emergency, if specifically requested by the JU or the Commission and within the deadline specified in the request] [Option B: not applicable]; (iii) other data, including associated metadata, as specified and within the deadlines laid down in the “data management plan” in Annex 1;

(b) provide information — via the repository — about tools and instruments at the disposal of the beneficiaries and necessary for validating the results (and — where possible — provide the tools and instruments themselves). […]

As an exception, the beneficiaries do not have to ensure open access to specific parts of their research data if the achievement of the action’s main objective, as described in Annex 1, would be jeopardized by making those specific parts of the research data openly accessible. In this case, the data management plan must contain the reasons for not giving access.]